Non-Invasive Prenatal Screening (NIPS) Market
Non-Invasive Prenatal Screening (NIPS) Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Non-Invasive Prenatal Screening (NIPS) Market Size and Growth
The Non-Invasive Prenatal Screening (NIPS) market is experiencing significant growth, driven by advancements in technology and increased demand for prenatal testing. The global market size is projected to reach approximately $3.5 billion by 2025, reflecting rising awareness and adoption among expectant parents and healthcare providers. Competitive dynamics shape the evolving landscape.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Myriad Genetics
◍ Illumina
◍ Progenity
◍ Natera
◍ Yourgene Health
◍ Roche Sequencing Solutions (RSS)
◍ Eurofins LifeCodexx GmbH
◍ Labcorp
◍ PerkinElmer
◍ Harmony
The Non-Invasive Prenatal Screening (NIPS) market features companies like Myriad Genetics, Illumina, Progenity, and Natera, providing innovative genetic testing solutions. These firms enhance market growth through advanced technologies and strategic partnerships, improving prenatal diagnostics. Notable revenues include Myriad Genetics ($271 million) and Illumina ($3.6 billion), driving industry expansion.
Request Sample Report
Market Segmentation
By Application
Clinical Laboratories
Hospital
Request Sample Report
By Product
Trisomy 21
Trisomy 18
Trisomy 13
Sex Chromosome Aneuploidies
Others
Market Growth
Request Sample Report
$ X Billion USD
